Vitamin K, Insulin Sensitivity and Cancer

As the epidemic of obesity continues to rise more research has been put into the causal results associated with being obese.  One of the major areas of concern and research is cancer. Research has unveiled the link between obesity, insulin resistance and cancer.  It is believed that Insulin/insulin-like growth factor (IGF) system may partly explain this effect. Basically insulin and IGF-1 act as important growth factors in enhancing tumor cell growth. Science is looking to Vitamin K as a possible solution.  

The research suggests vitamin K could be possible treatment for cancer.  Not only does vitamin K help to regulate glucose metabolism by converting to a substance called carboxylated osteocalcin in your body but it has also been shown to slow tumor growth in cancer; which may very well be associated with its ability to improve insulin sensitivity. My research lead me to consider cases of insulin sensitivity and cancer in non-obese people.  Is there a link between vitamin k deficiency and cancer ?  

The research is still unclear as to a definitive answer on this topic.  However, the wide variety of cancers that are treated with vitamin K suggests that their is a strong link between the two (learn more: http://www.k-vitamins.com/index.php?page=Cancer)  

References:Manna P. et al (2016) Beneficial role of vitamin K supplementation on insulin sensitivity, glucose metabolism, and the reduced risk of type 2 diabetes: A review.

Retrieved From: https://www.ncbi.nlm.nih.gov/pubmed/14713323

‍Additional Resources:http://care.diabetesjournals.org/content/31/11/2092http://care.diabetesjournals.org/content/34/9/e147